Related Experiment Video
Updated: Aug 21, 2026

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
DUSP12 Regulates NAT10-Mediated RNA Acetylation to Modulate DNA Repair and Therapeutic Response in Hepatocellular
Viktor Kalbermatter Boell1, Diana Reis Della Corte Guimarães Pacheco1, Yuli Thamires Magalhães1
1Department of Biochemistry Institute of Chemistry University of São Paulo (USP) São Paulo Brazil.
Abstract:
Hepatocellular carcinoma (HCC), an aggressive type of liver cancer, has limited treatment options, and chemotherapy remains an important clinical approach. This study investigates the role of dual-specificity phosphatase 12 (DUSP12) and its interaction with the nucleolar protein N-acetyltransferase 10 (NAT10) in HCC models under genotoxic stress. We demonstrate that doxorubicin (DX) induces greater cytotoxicity than cisplatin, correlating with a stronger DNA damage response (DDR), nucleolar stress, and NAT10 relocalization. CRISPR-Cas9-mediated DUSP12 knockout sensitized cells to DX, increasing markers of DNA damage (γH2AX, p53) and delaying DNA break repair. This was accompanied by redistribution of nucleolar proteins NAT10 and TCOF1. Remodelin treatment enhanced DX sensitivity in DUSP12 knockout cells, suggesting a context-dependent interaction between DUSP12 loss and the NAT10 inhibition. Protein interaction assays confirmed that DUSP12 binds NAT10, corroborating a regulatory interaction. DUSP12 deletion increased NAT10 phosphotyrosine levels and reduced N4-acetylcytidine (ac4C) RNA modification, consistent with altered NAT10-dependent RNA acetylation. Analysis of patient data revealed frequent DUSP12 amplification in HCC, whereas elevated DUSP12 expression was associated with poor survival and enrichment of DDR- and ribosome biogenesis-related transcriptional programs. Our findings identify the DUSP12-NAT10-ac4C axis as a novel molecular link between DDR and nucleolar stress, unveiling a potential therapeutic vulnerability in HCC.
Insights
Dual-specificity phosphatase 12 (DUSP12) and its interaction with N-acetyltransferase 10 (NAT10) were studied in liver cancer. DUSP12 loss enhances chemotherapy sensitivity by impacting DNA damage and RNA acetylation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is an aggressive liver cancer with limited therapeutic options.
- Chemotherapy remains a key treatment modality for HCC.
- Understanding molecular mechanisms driving HCC progression and treatment resistance is crucial.
Purpose of the Study:
- To investigate the role of dual-specificity phosphatase 12 (DUSP12) in HCC.
- To explore the interaction between DUSP12 and nucleolar protein N-acetyltransferase 10 (NAT10) under genotoxic stress.
- To identify potential therapeutic vulnerabilities in HCC.
Main Methods:
- Utilized CRISPR-Cas9 to create DUSP12 knockout HCC models.
- Administered genotoxic agents (doxorubicin, cisplatin) and Remodelin.
- Performed DNA damage response assays (γH2AX, p53), protein interaction studies, and RNA modification analysis (ac4C).
- Analyzed DUSP12 amplification and expression in HCC patient data.
Main Results:
- Doxorubicin induced greater cytotoxicity than cisplatin, linked to DNA damage response (DDR) and nucleolar stress.
- DUSP12 knockout sensitized HCC cells to doxorubicin, impairing DNA repair and altering NAT10 localization.
- DUSP12 interacts with NAT10, and DUSP12 deletion affects NAT10 activity and N4-acetylcytidine (ac4C) RNA modification.
- HCC patients with DUSP12 amplification or high expression showed poor survival and enriched DDR/ribosome biogenesis pathways.
Conclusions:
- The DUSP12-NAT10 axis is a novel link between DDR and nucleolar stress in HCC.
- DUSP12 loss represents a potential therapeutic vulnerability in liver cancer.
- Targeting the DUSP12-NAT10-ac4C pathway could offer new treatment strategies for HCC.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Abnormal Proliferation
Biosynthesis of Nucleic Acids

